Usana Health Sciences (USNA) Common Equity (2010 - 2026)

Usana Health Sciences (USNA) has 17 years of Common Equity data on file, last reported at $543.6 million in Q2 2026.

• On a quarterly basis, Common Equity rose 2.6% year-over-year to $543.6 million in Q2 2026; TTM through Apr 2026 was $543.6 million, a 2.6% increase from a year earlier, with the FY2026 full-year figure at $533.1 million, changed 0.19% from the prior year.
• Common Equity for Q2 2026 stood at $543.6 million, up from $533.1 million in the prior quarter.
• Over the last five years, Common Equity for USNA reached as high as $543.6 million in Q2 2026 and fell as low as $389.9 million in Q2 2022.
• Historically, Common Equity has averaged $478.7 million across 5 years, with a median of $497.2 million in 2023.
• Across the five-year window, Common Equity fell 10.53% in 2022 and climbed 16.77% in 2023, its largest moves.
• Year by year, Common Equity stood at $434.5 million in 2022, then gained by 14.44% to $497.2 million in 2023, then advanced by 7.02% to $532.1 million in 2024, then dropped by 0.76% to $528.1 million in 2025, then gained by 2.93% to $543.6 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $543.6 million in Q2 2026, $533.1 million in Q1 2026, and $528.1 million in Q3 2025.